Market watchers had a bearish view for MedTech stocks ahead of the first-quarter earnings season, thanks to the ongoing geopolitical discord across the globe with major complications arising from the Middle-East conflicts. Security threats around the Red Sea were alarming through the months of the first quarter, leading to a significant rise in freight costs and shipping times. Added to this, healthcare labor shortages continued to act as a major business disruptor.While these remarkably reduced the gross a ...